DalsnaFinance › Analyst accuracy › Baird › ABT target
Baird Initiates Coverage on Abbott Laboratories (ABT) Stock with Outperform Rating
setting a price objective of $121.00.
A fact about what Baird published, as reported by Yahoo Finance, not a recommendation from Dalsna Finance; Baird is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.